Status:
COMPLETED
miRNA Biomarkers in Multiple Sclerosis
Lead Sponsor:
University of Gaziantep
Conditions:
Multiple Sclerosis
miRNA
Eligibility:
All Genders
25+ years
Brief Summary
Multiple Sclerosis (MS) characterized by demyelination and axonal degeneration is a chronic inflammatory disease of the central nervous system (CNS). Recent studies have shown that dysregulated miRNAs...
Eligibility Criteria
Inclusion
- The age of 25 years and above
- at least one Central Nervous System (CNS) demyelination event
Exclusion
- with genetic diseases, hypertension, head trauma, neuropsychiatric disease, diabetes mellitus, hypertension, cardiac failure, hepatic failure, renal failure, Thalassemia, Sickle cell disease, iron deficiency, and B12 deficiency
Key Trial Info
Start Date :
May 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04772495
Start Date
May 1 2015
End Date
July 1 2017
Last Update
February 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.